Hyperactivity Disorder Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hyperactivity Disorder stocks.

Hyperactivity Disorder Stocks Recent News

Date Stock Title
Apr 30 LLY Stocks Keep Sinking, With Dow Losing 300 Points; IBD 50 Stock Hubbell Plunges
Apr 30 LLY Taxpayer to fork out £85bn to cover Bank of England losses
Apr 30 LLY Eli Lilly and Company (LLY) Q1 2024 Earnings Call Transcript
Apr 30 LLY Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Apr 30 LLY Lilly Soars as Forecast Boost Shows Weight-Loss Drugs’ Power
Apr 30 LLY IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Apr 30 LLY Eli Lilly and Company 2024 Q1 - Results - Earnings Call Presentation
Apr 30 LLY Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings
Apr 30 ALKS Alkermes Q1 2024 Earnings Preview
Apr 30 LLY Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Apr 30 LLY Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Apr 30 LLY Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
Apr 30 LLY US STOCKS-Wall St falls on hot labor costs data, caution before Fed verdict
Apr 30 LLY Why Eli Lilly Stock Is Jumping Today
Apr 30 LLY Eli Lilly stock jumps on weight-loss drug sales forecast
Apr 30 LLY Eli Lilly's GLP-1 demand drives up stock price post Q1 results
Apr 30 LLY US STOCKS-Wall St falls in lead up to Fed verdict after hot labor costs data
Apr 30 LLY Pre-Markets Sell on Last Trading Day of April
Apr 30 LLY Stocks to Watch Tuesday: PayPal, Eli Lilly, 3M, McDonald's
Apr 30 LLY Lilly (LLY) Reports Q1 Earnings: What Key Metrics Have to Say
Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is a mental disorder of the neurodevelopmental type. It is characterized by difficulty paying attention, excessive activity, or difficulty controlling behavior which is not appropriate for a person's age. The symptoms appear before a person is twelve years old, are present for more than six months, and may cause problems in at least two settings (such as school, home, or recreational activities). In children, problems paying attention may result in poor school performance. Additionally there is an association with other mental disorders and substance misuse. Although it causes impairment, particularly in modern society, many people with ADHD can have sustained attention span for tasks they find interesting or rewarding (known as hyperfocus).Despite being the most commonly studied and diagnosed mental disorder in children and adolescents, the exact cause is unknown in the majority of cases. It affects about 5–7% of children when diagnosed via the DSM-IV criteria and 1–2% when diagnosed via the ICD-10 criteria. As of 2015 it is estimated to affect about 51.1 million people globally. Rates are similar between countries and depend mostly on how it is diagnosed. ADHD is diagnosed approximately two times more often in boys than in girls, although the disorder is often overlooked in girls because their symptoms differ from those of boys. About 30–50% of people diagnosed in childhood continue to have symptoms into adulthood and between 2–5% of adults have the condition. In adults inner restlessness rather than hyperactivity may occur. The condition can be difficult to tell apart from other conditions, as well as to distinguish from high levels of activity that are still within the range of normative behaviors.ADHD management recommendations vary by country and usually involve some combination of counseling, lifestyle changes, and medications. The British guideline only recommends medications as a first-line treatment in children who have severe symptoms and for medication to be considered in those with moderate symptoms who either refuse or fail to improve with counseling, though for adults medications are a first-line treatment. Canadian and American guidelines recommend that medications and behavioral therapy be used together as a first-line therapy, except in preschool-aged children. Stimulant medication therapy is not recommended as a first-line therapy in preschool-aged children in either guideline. Treatment with stimulants is effective for at least 14 months; however, their long term effectiveness is unclear. Adults often develop coping skills which make up for some or all of their impairments.The medical literature has described symptoms similar to those of ADHD since the 18th century. ADHD, its diagnosis, and its treatment have been considered controversial since the 1970s. The controversies have involved clinicians, teachers, policymakers, parents, and the media. Topics include ADHD's causes and the use of stimulant medications in its treatment. Most healthcare providers accept ADHD as a genuine disorder in children and adults, and the debate in the scientific community mainly centers on how it is diagnosed and treated. The condition was officially known as attention-deficit disorder (ADD) from 1980 to 1987, while before this it was known as hyperkinetic reaction of childhood.

Browse All Tags